Literature DB >> 10817927

Activation of oncogenic pathways in degenerating neurons in Alzheimer disease.

X Zhu1, A K Raina, H Boux, Z L Simmons, A Takeda, M A Smith.   

Abstract

A number of recent findings have highlighted the similarities between neurogenesis during development and neurodegeneration during Alzheimer disease. In fact, neuronal populations that are known to degenerate in Alzheimer disease exhibit phenotypic changes characteristic of cells re-entering the cell division cycle. In this study, we extended these findings by investigating components of the cell cycle, known to trigger progression through G1 through activation of signal transduction cascades. Specifically, we found that proteins implicated in G1 transition, namely Cdc42/Rac, are upregulated in select neuronal populations in cases of Alzheimer disease in comparison to age-matched controls. Importantly, Cdc42/Rac shows considerable overlap with early cytoskeletal abnormalities suggesting that these changes are an extremely proximal event in the pathogenesis of the disease. Given the functional role of Cdc42/Rac in various cellular processes known to be perturbed in Alzheimer disease, namely cytoskeletal organization, oxidative balance, and oncogenic signaling, it is likely that increased neuronal Cdc42/Rac is highly significant in relation to the pathogenic process and contributes to neuronal degeneration. In fact, these findings suggest that Alzheimer disease is an oncogenic process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817927     DOI: 10.1016/s0736-5748(00)00010-1

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  33 in total

Review 1.  Cell cycle events in neurons. Proliferation or death?

Authors:  X Zhu; A K Raina; M A Smith
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Oxidative stress, cell cycle, and neurodegeneration.

Authors:  Jeffrey A Klein; Susan L Ackerman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 3.  Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

4.  Activation of ataxia telangiectasia muted under experimental models and human Parkinson's disease.

Authors:  Antoni Camins; Javier G Pizarro; Daniel Alvira; Javier Gutierrez-Cuesta; Aurelio Vazquez de la Torre; Jaume Folch; Francesc X Sureda; Ester Verdaguer; Felix Junyent; Joaquín Jordán; Isidre Ferrer; Mercè Pallàs
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

Review 5.  The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.

Authors:  Anna M Barron; Giuseppe Verdile; Ralph N Martins
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

6.  Inhibition of multiple pathways accounts for the antiapoptotic effects of flavopiridol on potassium withdrawal-induced apoptosis in neurons.

Authors:  Ester Verdaguer; Elvira G Jordà; Daniel Alvira; Andrés Jiménez; Anna Maria Canudas; Jaume Folch; Victor Rimbau; Mercè Pallàs; Antoni Camins
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

7.  Nonsteroidal anti-inflammatory drugs attenuate amyloid-β protein-induced actin cytoskeletal reorganization through Rho signaling modulation.

Authors:  Patricia Ferrera; Angélica Zepeda; Clorinda Arias
Journal:  Cell Mol Neurobiol       Date:  2017-01-25       Impact factor: 5.046

Review 8.  The potential role of rho GTPases in Alzheimer's disease pathogenesis.

Authors:  Silvia Bolognin; Erika Lorenzetto; Giovanni Diana; Mario Buffelli
Journal:  Mol Neurobiol       Date:  2014-01-23       Impact factor: 5.590

Review 9.  Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders.

Authors:  Roger Lefort
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

10.  Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease.

Authors:  David J Bonda; Teresa A Evans; Corrado Santocanale; Jesús Catalá Llosá; Jose Viña; Vladan P Bajic; Rudy J Castellani; Sandra L Siedlak; George Perry; Mark A Smith; Hyoung-gon Lee
Journal:  Aging (Albany NY)       Date:  2009-04       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.